This week, we are pleased to have Stewart Fossceco, Head of Non-Clinical and Diagnostics Statistics at Zoetis and an expert in pharmaceutical manufacturing and an expert in pharmaceutical manufacturing, join us on the Data in Biotech podcast. We sat down with Stewart to discuss implementing and improving Quality Assurance (QA) processes at every stage of biotech manufacturing, from optimizing assay design and minimizing variability in early drug development to scaling this up when moving to full production. Stewart talks from his experiences on the importance of experimental design, understand ..read more

This week, we are pleased to welcome Jacob Oppenheim, Entrepreneur in Residence at Digitalis Ventures, a venture capital firm that invests in solutions to complex problems in human and animal health. Jacob sat down with Ross to discuss the importance of establishing strong data foundations in biotech companies and how to approach the task. We explore the challenges biotech organisations face with existing tools. What are the limitations, and why are current data tools and systems not yet geared toward helping scientists themselves extract meaningful insights from the data? We also get Jacob’s ..read more

This week's guest is Joseph Pearson, Global Product Manager of OmicSoft at QIAGEN, a global provider of sample-to-insight solutions that enable customers to gain valuable molecular insights.   During this episode, we dive into OmicSoft, a powerful NGS analysis suite that can quickly explore and compare 500,000 curated omics samples from disease-related studies. Joseph outlines the challenges of acquiring and analysing NGS data sets, how customers can interact with OmicSoft data, and what he thinks of the build versus buy debate when selecting new bioinformatics tools. Data in Biotech ..read more

This week, we’re delighted to be joined by Annemie Ribbens, VP Science, Evidence and Trials at icometrix, a medical technology manufacturer that offers a portfolio of AI solutions to assist healthcare with various challenges in neurological disorders, such as brain trauma, strokes, dementia, and Alzheimer's disease. During this episode, Annemie opens up on icometrix’s mission in analyzing and treating neurological disorders, the work that went into developing the data infrastructure and the challenges they face when dealing with such large data sets. Annemie also goes on to discuss how ma ..read more

This week, we’re delighted to be joined by Lana Denysyk, Head of RWD Assets at Novo Nordisk. During this conversation, Lana shares how real-world data is used in biotech, diving into how it can help clinicians understand patient experiences outside clinical trials. Lana also discusses the challenges in acquiring and utilising real-world data, the importance of having a centralised team to manage it, and emerging data types like patient-reported outcomes and health equity data.  Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. Disc ..read more

This week, we're delighted to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect, and treat disease. Host Ross Katz speaks with Michelle on the use of biostatistics in the field of diagnostics, what biases can corrupt diagnostic tests and how to catch them early, the different types of data sets that are being used to develop diagnostic models and how to prepare to present data to regulatory bodies such as the FDA. --- If you’re a biotech company struggling to transform your business with data, CorrD ..read more